Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Bartonellosis Market CAGR Outlook And Future Development
The bartonellosis market has experienced rapid expansion in recent years. It is projected to grow from $1.3 billion in 2025 to $1.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. The historical growth can be linked to several factors, including the increasing incidence of cat scratch disease, advancements in diagnostic capabilities for infectious diseases, the availability of antibiotic therapies, the expansion of hospital diagnostic laboratories, and heightened clinician awareness of bartonella infections.
The bartonellosis market is projected to experience rapid growth in the next few years, set to reach $2.24 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period can be attributed to the increasing development of rapid diagnostic assays, a rising focus on early intervention in systemic infections, the expansion of specialized infectious disease care, a growing adoption of precision antibiotic regimens, and increasing investment in zoonotic disease research. Prominent trends throughout this period encompass the increasing adoption of molecular diagnostic techniques, a rising use of PCR-based testing, growing awareness of zoonotic infections, the expansion of targeted antibiotic treatment protocols, and an enhanced focus on early disease identification.
Get A Free Sample Report With In-Depth Market Insights:
Bartonellosis Market Expansion Drivers: What’s Shaping Future Growth?
The increasing occurrence of zoonotic diseases is anticipated to drive the expansion of the bartonellosis market in the future. These diseases are defined as ailments passed from animals to humans, either directly or via intermediary carriers. The heightened incidence of zoonotic diseases stems from various factors, including heightened interactions between humans and animals, shifts in the environment, deforestation, international travel, and the interspecies transmission of pathogens. Bartonellosis exemplifies zoonotic diseases, illustrating how bacterial pathogens carried by animal vectors like fleas, ticks, and lice can infect people, resulting in diverse clinical symptoms and underscoring the critical need to comprehend vector-borne disease transmission for public health. For example, in December 2024, the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), a Europe-based public health body, reported that human campylobacteriosis cases reached 148,181, marking a 4.3% year-over-year increase from 139,225 cases recorded in 2022. Likewise, salmonellosis cases increased to 77,486, showing a 16.9% rise when compared to 65,478 cases in 2022. Consequently, the escalating occurrence of zoonotic diseases is fueling the expansion of the bartonellosis market.
Bartonellosis Market Segmentation: How Does The Market Break Down By Category?
The bartonellosis market covered in this report is segmented –
1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types
2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing
3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications
2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections
3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections
4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis
Bartonellosis Market Strategic Trends: What Defines The Next Growth Phase?
Leading firms within the Bartonellosis market are prioritizing technological innovations, specifically multi-microbial phage modulation, to secure a competitive edge. This method, multi-microbial phage modulation, utilizes custom phage cocktails designed to concurrently target various intracellular pathogens, thereby tackling co-infections that often complicate Bartonella therapy. An example of this is Biologix Center, a US-based biotechnology firm, which launched Induced Native Phage Cocktails in November 2024, specifically formulated for individuals experiencing Bartonella and Babesia co-infections. This treatment offers pathogen-specific phage activation, daily adaptive dosing customized to each patient’s microbial profile, and improved penetration into stubborn infection reservoirs. Such innovation facilitates a holistic approach to intricate co-infections, lessens reliance on traditional antibiotics, and underpins precision medicine tactics. Through the application of multi-microbial phage therapy, companies are developing personalized treatment options within the Bartonellosis market, even as they navigate the clinical validation and regulatory processes typical for novel biologic therapies.
Bartonellosis Market Competitive Overview And Top Companies
Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio
View The Full Bartonellosis Market Report:
Bartonellosis Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the bartonellosis market in 2025. The regions covered in the bartonellosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









